Hepatitis B vaccine

This page covers all Hepatitis B vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Hepatitis B surface antigen (HBsAg).

Targets

Hepatitis B surface antigen (HBsAg)

Phase 3 pipeline (2)

• Engerix B Hepatitis B Vaccine · Tel-Aviv Sourasky Medical Center · Immunology
  Engerix B stimulates the immune system to produce antibodies against hepatitis B surface antigen, conferring protection against hepatitis B virus infection.
• Comparator: Comparator: ENGERIX-B · Merck Sharp & Dohme LLC · Immunology / Infectious Disease
  ENGERIX-B is a hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg).